Announced Wed, 24 Jun · 18:28 IST
Trading Window Closure for Q1 FY27 Results Period
Compliance View source PDF
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹11.55
prior close
₹11.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+2.2+1.9+1.4+1.0+1.3+1.0+3.0+1.9-3.0-5.7-10.0——
Up moveDown movePending
AI summary
Nectar Lifesciences has informed the exchanges that the trading window for its securities will remain closed from July 01, 2026, till 48 hours after the declaration of financial results for the quarter ended June 30, 2026. This is pursuant to SEBI insider trading regulations. Designated persons and their immediate relatives are prohibited from trading in company shares during this period. The Q1 results announcement is expected after the window reopens.
Likely market impact
Routine regulatory compliance filing. Signals upcoming Q1 FY27 earnings announcement but no direct impact on stock price or shareholders.